日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Staphylococcus aureus Formate--tetrahydrofolate ligase (fhs), partial CSB-YP409080FLG
CSB-EP409080FLG
CSB-BP409080FLG
CSB-MP409080FLG
CSB-EP409080FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus S-adenosylmethionine synthase (metK) CSB-YP409081FLG
CSB-EP409081FLG
CSB-BP409081FLG
CSB-MP409081FLG
CSB-EP409081FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Serine protease splB (splB) CSB-YP409082FLG
CSB-EP409082FLG
CSB-BP409082FLG
CSB-MP409082FLG
CSB-EP409082FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0754 membrane protein NWMN_1738 (NWMN_1738), partial CSB-YP409083FLG1
CSB-EP409083FLG1
CSB-BP409083FLG1
CSB-MP409083FLG1
CSB-EP409083FLG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP409084FLG
CSB-EP409084FLG
CSB-BP409084FLG
CSB-MP409084FLG
CSB-EP409084FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0316 protein NWMN_1849 (NWMN_1849), partial CSB-YP409085FLG1
CSB-EP409085FLG1
CSB-BP409085FLG1
CSB-MP409085FLG1
CSB-EP409085FLG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 2-isopropylmalate synthase (leuA), partial CSB-YP409086FLG
CSB-EP409086FLG
CSB-BP409086FLG
CSB-MP409086FLG
CSB-EP409086FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Potassium-transporting ATPase B chain (kdpB), partial CSB-YP409087FLG1
CSB-EP409087FLG1
CSB-BP409087FLG1
CSB-MP409087FLG1
CSB-EP409087FLG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Uracil phosphoribosyltransferase (upp) CSB-YP409088FLG
CSB-EP409088FLG
CSB-BP409088FLG
CSB-MP409088FLG
CSB-EP409088FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus S-ribosylhomocysteine lyase (luxS) CSB-YP409089FLG
CSB-EP409089FLG
CSB-BP409089FLG
CSB-MP409089FLG
CSB-EP409089FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Multidrug resistance efflux pump sepA (sepA), partial CSB-YP409090FLG1
CSB-EP409090FLG1
CSB-BP409090FLG1
CSB-MP409090FLG1
CSB-EP409090FLG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L13 (rplM) CSB-YP409091FLG
CSB-EP409091FLG
CSB-BP409091FLG
CSB-MP409091FLG
CSB-EP409091FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 30S ribosomal protein S5 (rpsE) CSB-YP409092FLG
CSB-BP409092FLG
CSB-MP409092FLG
CSB-EP409092FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L16 (rplP) CSB-YP409093FLG
CSB-EP409093FLG
CSB-BP409093FLG
CSB-MP409093FLG
CSB-EP409093FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L3 (rplC) CSB-YP409094FLG
CSB-EP409094FLG
CSB-BP409094FLG
CSB-MP409094FLG
CSB-EP409094FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Urease accessory protein UreD (ureD) CSB-YP409095FLG
CSB-EP409095FLG
CSB-BP409095FLG
CSB-MP409095FLG
CSB-EP409095FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Isopentenyl-diphosphate delta-isomerase (fni) CSB-YP409096FLG
CSB-EP409096FLG
CSB-BP409096FLG
CSB-MP409096FLG
CSB-EP409096FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Oxygen sensor histidine kinase nreB (nreB) CSB-YP409097FLG
CSB-EP409097FLG
CSB-BP409097FLG
CSB-MP409097FLG
CSB-EP409097FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP409098FLG
CSB-EP409098FLG
CSB-BP409098FLG
CSB-MP409098FLG
CSB-EP409098FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP409099FLG
CSB-EP409099FLG
CSB-BP409099FLG
CSB-MP409099FLG
CSB-EP409099FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×